Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/1993
12/28/1993US5273743 Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
12/28/1993US5273738 Administering a radiolabeled monoclonal antibody having a T-200 antigen-binding site; selective delivery
12/28/1993CA1325591C Method for treating malignancy and autoimmune disorders in humans
12/23/1993WO1993025244A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING
12/23/1993WO1993025243A2 Metal complexes formed with macrocyclic ligands for use in imaging techniques
12/23/1993WO1993025240A2 Pretargeting methods and compounds
12/22/1993EP0444194B1 Agent for thermotherapy
12/22/1993CN1079746A Ligands and cationic complexes thereof with technetium-99m
12/21/1993US5272263 DNA sequences encoding vascular cell adhesion molecules (VCAMS)
12/21/1993US5272082 Cytotoxic T-ALL cell lines and uses therefor
12/21/1993US5271927 Antibody conjugates with macrocyclic ligands
12/21/1993US5271924 Low molecular weight polysaccharide complexes for nuclear magnetic resonance imaging
12/21/1993US5271401 Radiological imaging method
12/15/1993EP0573577A1 TECHNETIUM-99m LABELING OF PROTEINS
12/15/1993EP0573545A1 Monoclonal antibodies against receptor-induced binding sites
12/15/1993CA2074665A1 Process for labeling substances with technetium or rhenium
12/15/1993CA2060537A1 Msh peptide derivatives
12/14/1993US5270030 Fibrin binding domain polypeptide and method of producing
12/09/1993WO1993024469A1 PROCESS FOR PRODUCING N-β-HYDROXYALKYL-TRI-N-CARBOXYALKYL-1,4,7,10-TETRAAZACYCLODODECANE AND N-β-HYDROXYALKYL-TRI-N-CARBOXYALKYL-1,4,8,11-TETRAAZACYCLOTETRADECANE DERIVATIVES AND THEIR METAL COMPLEXES
12/09/1993WO1993024457A1 Azavesamicols
12/09/1993WO1993021963A3 Carboxamide modified polyamine chelators and radioactive complexes and conjugation
12/09/1993DE4218744A1 Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe A process for the preparation of N-ß-Hxdroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecane and N-.beta.-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecane derivatives and metal complexes thereof
12/09/1993CA2134338A1 Azavesamicols
12/08/1993EP0428623A4 Production of radioiodinated 1--g(b)-d-arabinofuranosyl)-5(e)-(2-iodovinyl)uracil, and uses thereof, and related analogues incorporating alternative halogen radionuclides, the general radiohalogenation precursors, 1-(2,3,5-tri-o-acetyl--g(b)-d-arabinofuranosyl)-5(z and e)-(2-trimethylsilylvinyl)urac
12/07/1993US5268371 Containing a radioactive metal
12/07/1993US5268163 Method of preparing a radiolabelled technetium complex and kit for performing said method
12/07/1993US5268129 Layered mixed metal hydroxides for the stabilization of radioactive colloids
12/07/1993CA1324953C Bone marrow suppressing agents
12/07/1993CA1324877C Vertical reaction vessel
12/02/1993DE4217916A1 New heparin N-alkyl:amine and N-aralkyl:amine derivs. - useful as anticoagulants and intermediates for diagnostic tools
12/01/1993EP0571545A1 In situ synthesis of radiopharmaceuticals
11/1993
11/25/1993WO1993023854A1 Method of separating yttrium-90 from strontium-90
11/25/1993WO1993023743A1 Method of preparing a diagnostic agent for detecting inflammations
11/25/1993WO1993023537A1 Chimeric multivalent protein analogues and methods of use thereof
11/25/1993WO1993023085A1 TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING
11/25/1993WO1993023062A1 Therapeutic conjugates of toxins and drugs
11/25/1993WO1993020852A3 Macrocyclic chelating agents, chelates and conjugates thereof
11/25/1993CA2135882A1 Method of preparing a diagnostic agent for detecting inflammations
11/25/1993CA2135408A1 Chimeric multivalent protein analogues and methods of use thereof
11/24/1993EP0570575A1 Bicycloazamacrocyclophosphonic acid, conjugates, contrast agents and preparation
11/24/1993EP0570574A1 Bicyclopolyazamacrocyclophosphonic acid complexes, their preparation, conjugates and radiopharmaceuticals
11/24/1993EP0570493A1 TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING
11/24/1993EP0381763B1 Antibody modified with toxin
11/24/1993CN1022839C Functionized polymine cheiants and rhodium complexes thereof and process for their preparation
11/23/1993US5264570 Crown compounds phase transfer agent and tetraacetyl-2-trifluoromethanesulfonyl-2-deoxymannopyranose, heating in the presence of acid
11/18/1993EP0570022A2 Chelants possessing ortho ligating functionality and complexes thereof
11/18/1993EP0569583A1 Controlled use of polyether-substituted tumor agents in diagnosis and therapy
11/18/1993EP0569531A1 Stabilized antibody fragments
11/18/1993DE4310935A1 Microemulsions esp. for diagnosis and therapy of tumours - are protein-free and contain hydrophobic component of cholesterol ester and phospholipid(s) and opt. tri:glyceride(S) and/or free cholesterol
11/16/1993US5262403 Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness of metastatic profusion-II
11/16/1993US5262175 Stabilization of radiopharmaceutical compositions
11/16/1993US5262149 Method of treating or preventing alopecia
11/16/1993CA1324331C Monoclonal antibodies against e7 protein of human type 16 papillomavirus, a process for their preparation, and their use
11/16/1993CA1324317C Stable radiodiagnostic products, and the preparation thereof
11/11/1993WO1993022339A1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR
11/11/1993WO1993022275A1 Substituted 1,1,2-triphenylbutenes and their use in the treatment and diagnosis of cancer
11/11/1993WO1993021963A2 Carboxamide modified polyamine chelators and radioactive complexes and conjugation
11/11/1993WO1993021962A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING
11/11/1993WO1993021957A1 Complexing agents and targeting immunoreagents
11/11/1993WO1993021940A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
11/11/1993CA2135059A1 Complexing agents and targeting immunoreagents
11/11/1993CA2134772A1 Substituted 1 , 1, 2 - triphenylbutenes and their use in the treatment and diagnosis of cancer
11/11/1993CA2134544A1 Binding peptides which interact with ligand growth factors of the epidermal growth factor receptor and erbb-2 receptor
11/11/1993CA2133580A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
11/10/1993EP0569132A1 Improvements in radiolabelling
11/09/1993US5260422 MHC conjugates useful in ameliorating autoimmunity
11/03/1993EP0568323A1 Stable porfimer sodium compositions and methods for their manufacture
11/03/1993EP0567514A1 A METHOD AND A SYSTEM FOR ENHANCED $i(IN VIVO) CLEARANCE OF DIAGNOSTIC AND/OR THERAPEUTIC AGENTS BY EXTRACORPOREAL DEPLETION, AND THE USE OF SAID AGENTS FOR SAID PURPOSE
11/03/1993CN1022633C Preparation method of ligand
10/1993
10/31/1993WO1993022260A1 Radiolabelled compound formulations
10/28/1993WO1993021318A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
10/28/1993WO1993021226A1 Cartilage matrix protein and methods for use
10/28/1993WO1993021151A1 Substituted thioureas as bifunctional chelators
10/28/1993WO1993020852A2 Macrocyclic chelating agents, chelates and conjugates thereof
10/28/1993WO1993020841A1 Antibodies specific for carcinoma-associated antigens
10/28/1993CA2117780A1 Cartillage matrix protein and methods for use
10/28/1993CA2117775A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof
10/28/1993CA2117770A1 Substituted thioureas as bifunctional chelators
10/26/1993US5256398 Mixture of adenosine, or an adenosine antagonist, with an adenosine receptor
10/26/1993US5256395 Drug delivery by administering a receptor binding assay having a dual preferential monoclonal antibody conjugating with predetermined haptens
10/26/1993CA1323484C Preparation of tc-99m radiopharmaceuticals
10/20/1993EP0566166A1 Chelants possessing ortho ligating functionality and complexes thereof
10/20/1993EP0565530A1 Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis
10/19/1993US5254329 Method for improving visualization of serotonergic structures in nonhuman vertebrates
10/19/1993US5254328 Using an ion exchange membrane
10/19/1993US5253649 Process for the measurement of blood circulation by means of non-radioactive microspheres
10/14/1993WO1993019787A1 Radiopharmaceuticals for imaging the heart
10/14/1993WO1993019668A1 Method and kit for imaging and treating organs and tissues
10/13/1993EP0565449A1 Rhenium and Technetium labelling of hormones
10/13/1993EP0458886B1 Agents for diagnosing and treating melanomas, aromatic halogenated derivatives usable as such agents and their preparation
10/13/1993CN1022411C Process for preparing ligands nitrogenous cycle
10/12/1993US5252721 Radionuclide metal chelates, radiolabeling proteins
10/12/1993US5252720 Metal complexes of water soluble texaphyrins
10/06/1993EP0563328A1 ?99m Tc(III) MYOCARDIAL IMAGING AGENTS AND METHOD OF USE
10/06/1993EP0563278A1 Control of gene expression by ionizing radiation
10/06/1993EP0563042A1 Radionuclide labelled particles useful for radiation synovectomy
10/05/1993US5250702 Nonradioactive carriers for radioactive metal elements
10/05/1993US5250666 Medical diagnosis and therapy; antitumor and anticarcinogenic agents; target localization
09/1993
09/30/1993WO1993018797A1 Method of intraoperatively detecting and locating tumoral tissues
09/30/1993WO1993018792A1 Selective alteration of antibody immunogenicity
1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 243